Qvt Financial LP Roivant Sciences Ltd. Transaction History
Qvt Financial LP
- $1.04 Billion
- Q3 2024
A detailed history of Qvt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Qvt Financial LP holds 65,793,779 shares of ROIV stock, worth $752 Million. This represents 73.2% of its overall portfolio holdings.
Number of Shares
65,793,779
Previous 66,719,779
1.39%
Holding current value
$752 Million
Previous $705 Million
7.66%
% of portfolio
73.2%
Previous 72.99%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$754 Million6.27% of portfolio
-
Viking Global Investors LP54.1MShares$618 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$404 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.7MShares$339 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.05B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...